Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.79 |
| ▸ | ACE | P12821 | 3/20 | 0.73 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.70 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.70 |
| ▸ | ITGAL | P20701 | 3/20 | 0.70 |
| ▸ | TACR1 | P25103 | 1/20 | 0.69 |
| ▸ | ECE1 | P42892 | 6/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | APAF1 | O14727 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | FPR2 | P25090 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetyltryptophan SCHEMBL4216452 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL702442 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL29401158 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL57140 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL4216450 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL57141 | 1.00 | ALOX15 (0.79) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL23933298 | 0.99 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL1427071 | 0.99 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL1304487 | 0.99 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL | |
| Acetyltryptophan SCHEMBL11471934 | 0.99 | ALOX15 (0.77) | ALOX15ACEITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2025217615-A1 | METHODS FOR MAKING HUMAN GROWTH FACTOR CONCENTRATE AND COMPOSITIONS AND USES THEREOF | GMS CAPITAL PARTNERS LLC (US) | 2025-10-16 | — | — | WO | claimed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2025123045-A1 | PREDICTIVE AND DIAGNOSTIC SCREENING METHODS FOR ENDOMETRIAL CANCER | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2025-06-12 | — | — | WO | claimed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | claimed |
| WO-2025054552-A1 | PARTICLES AND SUSPENSIONS COMPRISING HYALURONAN DEGRADING AGENTS AND METHODS OF USE THEREOF | ELEKTROFI, INC. (US) | 2025-03-13 | — | — | WO | claimed |
| EP-4514324-A1 | INJECTABLE SUSPENSIONS | Elektrofi, Inc. (US) | 2025-03-05 | — | — | EP | claimed |
| EP-4508087-A1 | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTIC PROTEINS AND METHODS OF USE | Genentech, Inc. (US) | 2025-02-19 | — | — | EP | claimed |
| WO-2025032220-A1 | LIQUID BOTULINUM TOXIN FORMULATION AND USE THEREOF | MERZ PHARMA GMBH & CO. KGAA (DE) | 2025-02-13 | — | — | WO | claimed |
| EP-4437319-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | Matterworks Inc (US) | 2024-10-02 | — | — | EP | claimed |
| WO-2023201299-A1 | PHARMACEUTICAL COMPOSITIONS OF THERAPEUTIC PROTEINS AND METHODS OF USE | GENENTECH, INC. (US) | 2023-10-19 | — | — | WO | claimed |
| WO-2023019194-A9 | DRY POWDER COMPOSITIONS OF OIL-IN-WATER (O/W) EMULSION ADJUVANTED VACCINES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-09-14 | — | — | WO | claimed |
| EP-4216726-A1 | PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE | Biomedit, LLC (US) | 2023-08-02 | — | — | EP | claimed |
| WO-2023077166-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC (US) | 2023-05-04 | — | — | WO | claimed |
| WO-2023044076-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING NEURODEGENERATIVE DISEASES | MarvelBiome, Inc. (US) | 2023-03-23 | — | — | WO | claimed |
| WO-2023019192-A1 | DRY LIPOSOME FORMULATIONS AND RELATED METHODS THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-02-16 | — | — | WO | claimed |
| WO-2023019194-A1 | DRY POWDER COMPOSITIONS OF OIL-IN-WATER (O/W) EMULSION ADJUVANTED VACCINES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-02-16 | — | — | WO | claimed |
| EP-4121131-A1 | REACTIVE HYDROGEL FORMING FORMULATIONS AND RELATED METHODS | Bard Peripheral Vascular, Inc. (US) | 2023-01-25 | — | — | EP | claimed |
| WO-2021189024-A9 | REACTIVE HYDROGEL FORMING FORMULATIONS AND RELATED METHODS | BARD PERIPHERAL VASCULAR, INC. (US) | 2022-10-06 | — | — | WO | claimed |
| WO-2022067052-A1 | PROBIOTIC BACILLUS COMPOSITIONS AND METHODS OF USE | ELANCO US INC. (US) | 2022-03-31 | — | — | WO | claimed |